259 related articles for article (PubMed ID: 31956052)
21. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
22. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.
Yoshida Y; Yamamura J; Sato H; Koyasu M; Obara Y; Sekiguchi H; Kawana T; Shiraki K
J Dermatol Sci; 1996 Dec; 13(3):237-41. PubMed ID: 9023706
[TBL] [Abstract][Full Text] [Related]
24. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
[TBL] [Abstract][Full Text] [Related]
25. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
26. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
[TBL] [Abstract][Full Text] [Related]
27. Antiviral activity of esterified alpha-lactalbumin and beta-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines.
Sitohy M; Billaudel S; Haertlé T; Chobert JM
J Agric Food Chem; 2007 Dec; 55(25):10214-20. PubMed ID: 17990848
[TBL] [Abstract][Full Text] [Related]
28. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
[TBL] [Abstract][Full Text] [Related]
30. Attachment and penetration of acyclovir-resistant herpes simplex virus are inhibited by Melissa officinalis extract.
Astani A; Navid MH; Schnitzler P
Phytother Res; 2014 Oct; 28(10):1547-52. PubMed ID: 24817544
[TBL] [Abstract][Full Text] [Related]
31. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
[TBL] [Abstract][Full Text] [Related]
32. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.
Andersen JH; Jenssen H; Gutteberg TJ
Antiviral Res; 2003 May; 58(3):209-15. PubMed ID: 12767468
[TBL] [Abstract][Full Text] [Related]
33. An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.
Park PJ; Antoine TE; Farooq AV; Valyi-Nagy T; Shukla D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6373-81. PubMed ID: 23989188
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.
Thompson KD
Antiviral Res; 1998 Jul; 39(1):55-61. PubMed ID: 9754950
[TBL] [Abstract][Full Text] [Related]
35. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment.
Wang LX; Takayama-Ito M; Kinoshita-Yamaguchi H; Kakiuchi S; Suzutani T; Nakamichi K; Lim CK; Kurane I; Saijo M
Jpn J Infect Dis; 2013; 66(5):404-10. PubMed ID: 24047739
[TBL] [Abstract][Full Text] [Related]
36. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir.
Danve C; Morfin F; Thouvenot D; Aymard M
J Virol Methods; 2002 Sep; 105(2):207-17. PubMed ID: 12270654
[TBL] [Abstract][Full Text] [Related]
37. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
38. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
39. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
[TBL] [Abstract][Full Text] [Related]
40. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
Schuhmacher A; Reichling J; Schnitzler P
Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
